Abstract: Active pixels sensors based on the DEPFET technology will be used for the innermost vertex detector of the future Belle-II experiment. The increased luminosity of the e(+) e(-) SuperKEKB collider entails challenging detector requirements, namely: low material budget, low power consumption, high precision and efficiency, and a large readout rate. The DEPFET active pixel technology has shown to be a suitable solution for this purpose. A review of the different aspects of the detector design (sensors, readout ASICS and supplementary infrastructure) and the results of the latest thinned sensor prototypes (50 μm) are described.

Abstract: NEXT is a new experiment to search for neutrinoless double beta decay using a 100 kg radio-pure high-pressure gaseous xenon TPC. The detector requires excellent energy resolution, which can be achieved in a Xe TPC with electroluminescence readout. Hamamatsu R8520-06SEL photomultipliers are good candidates for the scintillation readout. The performance of this photomultiplier, used as VUV photosensor in a gas proportional scintillation counter, was investigated. Initial results for the detection of primary and secondary scintillation produced as a result of the interaction of 5.9 keV X-rays in gaseous xenon, at room temperature and at pressures up to 3 bar, are presented. An energy resolution of 8.0% was obtained for secondary scintillation produced by 5.9 keV X-rays. No significant variation of the primary scintillation was observed for different pressures (1, 2 and 3 bar) and for electric fields up to 0.8 V cm(-1) torr(-1) in the drift region, demonstrating negligible recombination luminescence. A primary scintillation yield of 81 +/- 7 photons was obtained for 5.9 keV X-rays, corresponding to a mean energy of 72 +/- 6 eV to produce a primary scintillation photon in xenon.

Abstract: Charged particle therapy, or so-called hadrontherapy, is developing very rapidly. There is large pressure on the scientific community to deliver dedicated accelerators, providing the best possible treatment modalities at the lowest cost. In this context, the Italian research Foundation TERA is developing fast-cycling accelerators, dubbed 'cyclinacs'. These are a combination of a cyclotron (accelerating ions to a fixed initial energy) followed by a high gradient linac boosting the ions energy up to the maximum needed for medical therapy. The linac is powered by many independently controlled klystrons to vary the beam energy from one pulse to the next. This accelerator is best suited to treat moving organs with a 4D multipainting spot scanning technique. A dual proton/carbon ion cyclinac is here presented. It consists of an Electron Beam Ion Source, a superconducting isochronous cyclotron and a high-gradient linac. All these machines are pulsed at high repetition rate (100-400 Hz). The source should deliver both C6+ and H-2(+) ions in short pulses (1.5 μs flat-top) and with sufficient intensity (at least 10(8) fully stripped carbon ions per pulse at 300 Hz). The cyclotron accelerates the ions to 120 MeV/u. It features a compact design (with superconducting coils) and a low power consumption. The linac has a novel C-band high-gradient structure and accelerates the ions to variable energies up to 400 MeV/u. High RF frequencies lead to power consumptions which are much lower than the ones of synchrotrons for the same ion extraction energy. This work is part of a collaboration with the CLIC group, which is working at CERN on high-gradient electron-positron colliders.